ClinicalTrials.gov
public full text
Public Domain
Obinutuzumab in Systemic Sclerosis
The purpose of this study is to determine if obinutuzumab is effective in systemic sclerosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis#674829
- A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)#1195970
- A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women#1185144
- Treatment Interruption of Natalizumab#1369802
- Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment#366697
Record · ID 1243349
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive